Abu Dhabi, UAE – August 2026 — Emerging Global Technologies (EGT), a leading healthcare technology partner in the Middle East, today announced an expanded strategic partnership with Koios Medical, an award-winning AI company specializing in ultrasound diagnostics, to accelerate the adoption of advanced AI solutions across the GCC.
This partnership goes beyond traditional distribution. EGT will act as a true strategic extension of Koios Medical in the region, combining commercial execution, clinical engagement, and market development to drive meaningful and scalable adoption of AI in diagnostic imaging.
As part of this long-term commitment, EGT has also taken an equity stake in Koios Medical, reinforcing its confidence in the company’s technology, vision, and global growth trajectory. This investment reflects a shared ambition to build sustainable value for healthcare providers and patients across the region.
Under the partnership, EGT will lead the commercialization and deployment of Koios Medical’s flagship solutions—Koios DS™ Breast and Koios DS™ Thyroid—across key GCC markets including the UAE, Saudi Arabia, and Qatar. These AI-powered tools provide real-time, evidence-based risk assessment, supporting radiologists in improving diagnostic accuracy, reducing variability, and standardizing reporting in line with BI-RADS® and TI-RADS® guidelines.
Koios Medical continues to gain strong global traction, with leading institutions such as Al Habib Suleman, MD Anderson Madrid, King Chula Thailand, Northwestern Medicine, Mayo Clinic , and Mass General Brigham adopting its solutions, alongside expanding deployments at Mount Sinai and Yale New Haven Health.
“Our role is not to distribute technology, but to build markets around it,” said Sassine Mazraani, CEO of EGT. “By partnering and investing in Koios Medical, acting as their extended arm in the GCC, we are committing to long-term value creation—bringing proven AI into clinical practice and ensuring it delivers real impact for our customers.”
EGT’s deep regional expertise, combined with its established network across healthcare systems and regulatory bodies, uniquely positions the company to accelerate the adoption of clinically validated AI solutions.
“Our partnership with Emerging Global Technologies reflects our shared vision for scaling impactful AI globally,” said Chad McClennan, President & CEO of Koios Medical. “The GCC’s commitment to excellence, combined with EGT’s strong regional presence, positions us to rapidly expand access to our innovative technology. Together, we will support clinicians in delivering high-quality patient care, improving outcomes, and reducing the burden on strained human and financial resources.”
As healthcare systems across the GCC continue to prioritize innovation, efficiency, and improved patient outcomes, working together EGT and Koios Medical are positioned to lead the next wave of AI-driven transformation in diagnostic imaging—moving beyond pilot projects to real, enterprise-wide adoption and measurable results.
For more information about Emerging Global Technologies and Koios Medical, please visit www.egtmea.com and www.koiosmedical.com, respectively.
About Emerging Global Technologies
Emerging Global Technologies, your trusted healthcare technology partner in the MENA region. With over two decades of experience, we are recognized as an innovative, forward-looking company dedicated to revolutionizing the healthcare technology landscape. As pioneers in the field, we introduced voice recognition, Digital ID, Single Sign-on, and are now at the forefront of AI with predictive diagnosis and life-saving solutions. Our client-centric approach focuses on delivering tailored solutions, and our commitment to continuous development ensures our team is equipped with the latest technologies.
About Koios Medical
Koios Medical is an award-winning AI company specializing in ultrasound diagnostics. Its flagship solutions, Koios DS™ Breast and Koios DS™ Thyroid, provide real-time, evidence-based risk assessment to support clinicians in improving diagnostic accuracy, reducing variability, and standardizing reporting in line with BI-RADS® and TI-RADS® guidelines. By combining artificial intelligence with clinical expertise, Koios Medical helps healthcare providers make more confident decisions, improve patient outcomes, and reduce the burden on strained human and financial resources.